Imaging plays a pivotal role in systemic sclerosis for both diagnosis management of pulmonary complications, and high‐resolution computed tomography (HRCT) is the most sensitive technique for the evaluation of systemic sclerosis‐associated interstitial lung disease (SSc‐ILD).
Indeed, several studies have demonstrated that HRCT helps radiologists and clinicians to make a correct diagnosis on the basis of recognised typical patterns for SSc‐ILD. Most SSc patients affected by ILD have a non‐specific interstitial pneumonia pattern (NISP) on HRCT scan, whilst a minority of cases fulfil the criteria for usual interstitial pneumonia (UIP). Moreover, several recent studies have demonstrated that lung ultrasound (LUS) is an emergent tool in SSc diagnosis and follow‐up, although its role is still to be confirmed. Therefore, this article aims at evaluating the role of LUS in SSc screening, aimed at limiting the use of CT to selected cases.
